Form 4: Arteris Director Sells Shares Under Pre-Arranged Trading Plan
Insider Trading Report
Arteris, Inc. Director and 10% Owner Saiyed Atiq Raza sold 1,136 shares of common stock at $10 per share on July 18, 2025, pursuant to a Rule 10b5-1 trading plan.
Summary
- Saiyed Atiq Raza, a Director and 10% Owner of Arteris, Inc. (AIP), reported a sale of common stock.
- The transaction involved the disposition of 1,136 shares of Arteris common stock.
- The shares were sold at a price of $10 per share.
- The sale occurred on July 18, 2025.
- This transaction was executed under a Rule 10b5-1 trading plan, which was adopted by Mr. Raza on June 6, 2024.
- Following this transaction, Mr. Raza directly beneficially owns 20,839 shares of common stock.
- Additionally, 682,662 shares are indirectly beneficially owned through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which Mr. Raza serves as trustee.
Sentiment
Score: 5
Explanation: The transaction is a sale by an insider, which can be perceived negatively. However, it was conducted under a pre-arranged 10b5-1 trading plan, which indicates it was not based on new, non-public information, thus mitigating the negative signaling effect. Overall, it's a neutral event from a sentiment perspective.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This Form 4 filing reports a routine insider transaction under a pre-arranged trading plan, which is a common practice for corporate insiders to manage their equity holdings in compliance with securities laws. It does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: The sale of shares by a director and 10% owner could be interpreted by some shareholders as a reduction in insider confidence, although the 10b5-1 plan mitigates this interpretation.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date the 10b5-1 trading plan was adopted by Saiyed Atiq Raza. |
| 07/18/2025 | Date of the reported transaction (sale of common stock). |
| 07/21/2025 | Date the Form 4 was signed by Paul Alpern, as Attorney-in-Fact for S. Atiq Raza. |
Keywords
Arteris Inc., AIP, Saiyed Atiq Raza, Insider Trading, Form 4, Beneficial Ownership, 10b5-1 Plan, Stock Sale, Director, 10% Owner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.